An international team of cancer researchers has thrown a fresh grenade into the vaping debate, concluding that nicotine‑based e‑cigarettes are likely to cause lung and oral cancers. Their review pooled human biomarker studies, animal bioassays and lab experiments, and argues that the biological warning signs for tumor development are already blinking. Local news coverage on June 23 helped shove the study back into the center of the public conversation about youth vaping and federal policy.
According to UNSW, the analysis was led by cancer researchers at the University of New South Wales in Sydney and was published March 30 in the peer‑reviewed journal Carcinogenesis. The authors say they reviewed studies from 2017 through 2025 to assess whether e‑cigarettes might be carcinogenic independent of combustible tobacco.
What the review found
The paper's abstract states that “nicotine‑based e‑cigarettes are likely to be carcinogenic to humans who use them causing an indeterminate burden of oral cancer and lung cancer,” and the authors point to biomarker studies, mechanistic lab work and rodent bioassays as evidence. Their synthesis highlights DNA damage, oxidative stress and tissue inflammation in oral and respiratory tissue, plus chemical signals such as nitrosamines, volatile organic compounds and certain metals found in vape aerosols. Carcinogenesis lays out those findings in detail.
U.S. public‑health context
U.S. health agencies already warn that e‑cigarette aerosol can contain cancer‑causing chemicals and tiny particles that reach deep into the lungs, though long‑term population risk estimates are still emerging, per the CDC. National surveillance also shows vaping remains the most common tobacco product among young people: the 2024 National Youth Tobacco Survey put current youth e‑cigarette use at roughly 1.6 million students. Recent CDC data underline why researchers and regulators are watching these trends so closely.
Experts push back
Several independent scientists told the Science Media Centre that the review overstates what the available evidence can prove, noting it did not follow standard systematic‑review methods and at times equates trace chemical detection with meaningful human risk. As Prof. Peter Hajek put it in that compilation, “The review's conclusions are misleading.” Other critics and media analysts have also flagged methodological problems and selective citation in the wider literature, as detailed by Filter.
Regulatory fallout and what it means
The UNSW review lands as U.S. regulators have shifted enforcement and, in May 2026, the FDA issued marketing‑granted orders for a small number of products, including the first non‑tobacco fruit‑flavored pods, a move the American Lung Association criticized for risking youth appeal. Local coverage of the UNSW findings, including a FOX 5 Atlanta segment on June 23, has reignited debates about flavor policy, enforcement and how regulators should weigh uncertain long‑term risks.
Bottom line for readers
The review adds biological evidence that vaping can harm oral and respiratory tissue, but experts disagree about how much those signals translate into real‑world cancer risk in people. Public‑health groups continue to advise that never‑smokers, especially young people, should avoid e‑cigarettes, while smokers who want to quit should talk with clinicians about proven cessation tools, according to the American Cancer Society and CDC guidance.
